Wellington Shields & Co’s Merck MRK Stock Holding History

Wellington Shields & Co’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.8M	Sell	23,266 -100	-0.4%	-$11.5K	0.71%	31
2025 Q4	$2.46M	Sell	23,366 -925	-4%	-$86.8K	0.61%	39
2025 Q3	$2.04M	Sell	24,291 -5,606	-19%	-$462K	0.53%	41
2025 Q2	$2.37M	Buy	29,897 +3,756	+14%	+$299K	0.67%	34
2025 Q1	$2.35M	Sell	26,141 -75	-0.3%	-$7K	0.73%	28
2024 Q4	$2.61M	Sell	26,216 -200	-0.8%	-$20.6K	0.8%	25
2024 Q3	$3M	Sell	26,416 -100	-0.4%	-$11.9K	0.91%	22
2024 Q2	$3.28M	Buy	26,516 +350	+1%	+$45.1K	1.07%	17
2024 Q1	$3.45M	Hold	26,166	–	–	1.16%	19
2023 Q4	$2.85M	Sell	26,166 -450	-2%	-$46.7K	1.05%	20
2023 Q3	$2.74M	Buy	26,616 +1,500	+6%	+$162K	0.69%	18
2023 Q2	$2.9M	Sell	25,116 -1,750	-7%	-$199K	0.68%	17
2023 Q1	$2.86M	Buy	26,866 +1,356	+5%	+$146K	0.64%	20
2022 Q4	$2.83M	Sell	25,510 -900	-3%	-$92K	0.64%	17
2022 Q3	$2.27M	Buy	26,410 +400	+2%	+$35.7K	0.99%	24
2022 Q2	$2.37M	Hold	26,010	–	–	0.57%	24
2022 Q1	$2.13M	Sell	26,010 -100	-0.4%	-$7.88K	0.7%	33
2021 Q4	$2M	Buy	26,110 +700	+3%	+$55.8K	0.4%	35
2021 Q3	$1.91M	Buy	25,410 +1,000	+4%	+$76.1K	0.67%	33
2021 Q2	$1.9M	Sell	24,410 -1,601	-6%	-$119K	0.63%	36
2021 Q1	$1.91M	Buy	26,011 +628	+2%	+$46.3K	0.69%	34
2020 Q4	$1.98M	Buy	25,383 +2,306	+10%	+$176K	0.71%	30
2020 Q3	$1.83M	Buy	23,077 +498	+2%	+$39K	0.77%	31
2020 Q2	$1.67M	Buy	22,579 +209	+0.9%	+$15.7K	0.73%	35
2020 Q1	$1.64M	Buy	22,370 +4,847	+28%	+$381K	0.91%	29
2019 Q4	$1.52M	Buy	17,523 +11,602	+196%	+$953K	0.67%	41
2019 Q3	$476K	Sell	5,921 -10,648	-64%	-$853K	0.74%	51
2019 Q2	$1.33M	Hold	16,569	–	–	0.63%	44
2019 Q1	$1.31M	Hold	16,569	–	–	0.67%	43
2018 Q4	$1.21M	Buy	16,569 +3,438	+26%	+$243K	0.69%	40
2018 Q3	$889K	Sell	13,131 -420	-3%	-$26.8K	0.48%	52
2018 Q2	$785K	Hold	13,551	–	–	0.41%	58
2018 Q1	$704K	Hold	13,551	–	–	0.38%	63
2017 Q4	$728K	Hold	13,551	–	–	0.39%	62
2017 Q3	$828K	Hold	13,551	–	–	0.27%	55
2017 Q2	$829K	Hold	13,551	–	–	0.29%	44
2017 Q1	$822K	Hold	13,551	–	–	0.25%	43
2016 Q4	$761K	Hold	13,551	–	–	0.4%	46
2016 Q3	$807K	Hold	13,551	–	–	0.41%	43
2016 Q2	$745K	Hold	13,551	–	–	0.46%	42
2016 Q1	$684K	Buy	13,551 +944	+7%	+$46.2K	0.46%	40
2015 Q4	$635K	Hold	12,607	–	–	0.42%	43
2015 Q3	$594K	Hold	12,607	–	–	0.45%	41
2015 Q2	$685K	Hold	12,607	–	–	0.23%	44
2015 Q1	$691K	Buy	12,607 +131	+1%	+$7.42K	0.41%	45
2014 Q4	$676K	Buy	12,476 +8,883	+247%	+$495K	0.39%	46
2014 Q3	$203K	Sell	3,593 -6,473	-64%	-$363K	0.13%	105
2014 Q2	$556K	Hold	10,066	–	–	0.35%	53
2014 Q1	$545K	Sell	10,066 -524	-5%	-$27.1K	0.34%	53
2013 Q4	$506K	Sell	10,590 -236	-2%	-$10.8K	0.34%	59
2013 Q3	$492K	Hold	10,826	–	–	0.39%	57
2013 Q2	$480	Buy	+10,826	New	+$484K	0.01%	64

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Shields & Co's MRK Position: Q1 2026 in Review

Wellington Shields & Co reduced its Merck (MRK) stake by 0.43% in Q1 2026, selling an estimated $11.5K and leaving 23,266 shares worth $2.8M. The position accounts for 0.71% of the portfolio, ranked #31.

Wellington Shields & Co first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.45M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Wellington Shields & Co held 23,266 shares of Merck worth $2.8M as of Q1 2026.
Wellington Shields & Co sold 100 Merck shares in Q1 2026, an estimated $11.5K.
Merck made up 0.71% of Wellington Shields & Co's portfolio in Q1 2026, its #31 holding.
Wellington Shields & Co first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
Wellington Shields & Co's Merck position peaked at $3.45M in Q1 2024.
3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Wellington Shields & Co's 13F filing for Q1 2026, filed 4 May 2026.